Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Kangtong Medical (301515) as of December 30, 2025, showing a decline in stock price and mixed capital flow [1][2] - Kangtong Medical reported a main revenue of 344 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 30.06% [2] - The company experienced a net profit loss of 10.21 million yuan for the same period, with a significant year-on-year decline of 150.92% [2] Group 2 - In Q3 2025, Kangtong Medical's quarterly main revenue was 79.12 million yuan, reflecting a year-on-year increase of 42.81% [2] - The company's net profit for Q3 2025 was a loss of 1.80 million yuan, down 138.94% year-on-year [2] - The debt ratio of Kangtong Medical stands at 40.94%, with a gross profit margin of 22.45% [2]
股票行情快报：港通医疗（301515）12月30日主力资金净买入106.42万元